Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Addition of Rituximab to Leflunomide in Active Rheumatoid Arthritis
NCT01244958Phase 3Completed
- Start
- Aug 2010
- Primary completion
- Feb 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA). Started Aug 2010; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01244958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244958.